banner

Shaping the Next Generation Pharmaceutical Supply Chain Control Tower with Autonomous Intelligence

Matthew Liotine

Abstract


This paper summarizes the findings of an industry panel study evaluating how new Autonomous Intelligence technologies, such as artificial intelligence and machine learning, impact the system and operational architecture of supply chain control tower (CT) implementations that serve the pharmaceutical industry. Such technologies can shift CTs to a model in which real-time information gathering, analysis, and decision making are possible. This can be achieved by leveraging these technologies to better manage decision complexity and execute decisions at levels that cannot otherwise be managed easily by humans. Some of the key points identified are in the areas of the fundamental capabilities that need to be supported and the improved level of decision visibility that they provide. We also consider some the challenges in achieving this, which include data quality and integrity, collaboration and data sharing across supply chain tiers, cross-system interoperability, decision-validation and organizational impacts, among others.


Full Text:

PDF

References


1. Trzuskawska-Grzesi?ska A. Control Towers in Supply Chain Management - Past and Future. Journal of Economics and Management. 2017; 27 (1): p. 117-119.

2. Linton JD. Emerging Technology Supply Chains. Technovation. 2017;: p. 1-3.

3. MPO Objects. Modern Control Towers: Choosing the Right One for Your Digital Supply Chain. White Paper. ; 2017.

4. Baumgrass A, Dijkman R, Grefen P, Pourmirza S, Vlzer H, Weske M. A Software Architecture for a Transportation Control Tower. Beta Working Paper series 461. Beta Research School for Operations Management and Logistics; 2014.

5. Hofman W. Control Tower Architecture for Multi and Synchromodal. In ILS 2014 5th International Conference; 2014; Breda.

6. Mabert VA, Venkataraamanan MA. Special Research Focus on Supply Chain Linkages: Challenges for Design and Management in the 21st Centruy. Decision Sciences. ; 29(3): p. 537-552.

7. Accenture. Prepare for Takeoff with a Supply Chain Control Tower. ; 2014.

8. Trzuskawska-Grzesi?ska A. Control Towers in Supply Chain Management - Past and Future. Journal of Economics and Management. 2017; 27(1): p. 117-124.

9. Lee BK, Zhou R, deSouza R, Park J. Data-Driven Risk Measurement o fFirm-to-Firm Relationships in a Supply Chain. International Journal of Production Economics. 2016; 180: p. 148-157.

10. Singh RK, Kumar R, Kumar P. Strategic Issues in Pharmaceutical Supply Chains: A Review. International Journal of Pharmaceutical and Healthcare Marketing. 2016; 10(3): p. 234-257.

11. Accenture. Creating a Supply Chain Control Tower in the High-Tech Industry. ; 2015.

12. Hansen KR, Grunow M. Planning Operations Before Market Launch for Balancing Time-to-Market and Risks in Pharmaceutical Supply Chains. International Journal of Production Economics. 2015; 161: p. 129-139.

13. Chen X, Yang H, Wang X. Effects of Price Cap Regulation on the Pharmaceutical Supply Chain. Journal of Business Research. 2018;: p. 1-3.

14. Papert M, Rimpler P, Pflaum A. Enhancing Supply Chain Visibility in a Pharmaceutical Supply Chain. International Journal of Physical Distribution & Logistics Management. 2016; 46(9): p. 859-884.

15. Liotine M, Pagano A, Gadiraju SV. Technology Trends in Logistics and Supply Chain Management. In Pagano AM, Gyimah M. Contemporary Issues in Supply Chain Management and Logistics. New York: Business Expert Press; 2017. p. 6-29.

16. Swaminathan J, Smith SF, Sadeh NM. Modeling Supply Chain Dynamics: A Multi-Agent Approach. Decision Sciences. 1998; 29(3): p. 607-631.

17. Wu DJ, Zhong F, Kimbrough SO. Computers Play the Beer Game: Can Artificial Agents Manage Supply Chains? Decision Support Systems. 2002; 33: p. 331-332.

18. Bughin J, Hazan E, Ramaswamy S, et. al. Artifical Intelligence: The Next Digital Frontier. Discussion Paper. McKinsey Global Institute; 2017.

19. Lippincott S. Control Tower Technology Value Matrix 2017. Research Note. Nucleus Research; 2017.

20. Fox M, Barbuceanu M, Teigen R. Agent-Oriented Supply-Chain Management. The International Journal of Flexible Manufacturing Systems. 2000; 12: p. 165-188.

21. Shah N. Pharmaceutical Supply Chains: Key Issues and Strategies for Optimisation. Computers and Chemical Engineering. 2004; 28: p. 929-941.

22. A Composite Framework of Supply Chain Management and Enterprise Planning for Small and Medium Sized Manufacturing Enterprises. Supply Chain Management: An International Journal. 2008; 13(5): p. 349-355.




DOI: https://doi.org/10.32629/jai.v2i1.34

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Matthew Liotine

License URL: https://creativecommons.org/licenses/by-nc/4.0